Optimization of class II BCS drug using solid dispersion technique

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL. 5, 2012, Pages 554-571

  El Nabarawi, M A ^a,b   El Miligi, M F ^a,b   Khalil, I A ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Misr University for Science and Technology   (Egypt)

Author keywords

Aceclofenac; Carrier; Dissolution; Solid dispersion; Solubility

Indexed keywords

ACECLOFENAC; POLYMER;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; SOLID DISPERSION; X RAY DIFFRACTION;

EID: 84870766123     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Yu, L.X. et al. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharmaceutical research 19, 921-925 (2002).
2. Polli, J.E. et al. Summary workshop report: Biopharmaceutics classification system-Implementation challenges and extension opportunities. Journal of pharmaceutical sciences 93, 1375-1381 (2004).
3. Yu, L.X. Pharmaceutical quality by design: product and process development, understanding, and control. Pharmaceutical Research 25, 781-791 (2008).
4. Tran, T.T.D., Tran, P.H.L. & Lee, B.J. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug. European Journal of Pharmaceutics and Biopharmaceutics 72, 83-90 (2009).
5. Deshmukh, K.R. & Jain, S.K. Development of Aceclofenac Mouth Dissolving Tablets using Solid Dispersion Technique: In-vitro Evaluation. Indian Journal of Pharmaceutical Education and Research 46, 97-104 (2012).
6. Aejaz A, A.K.S.S.M.A.A. Formulation and invitroevauluation of aceclofenac solid dispersion incorporated gels. International Journal of Applied Pharmaceutics 2, 7-12 (2010).
7. Dahiya, S. Studies on formulation development of a poorly water-soluble drug through solid dispersion technique. Thai Journal of pharmaceutical Sciences 34, 77-87 (2010).
8. Gupta, S. &Saini, L. Effect of lyophilization and polymer compositions on solubility of aceclofenac solid dispersions. Journal of Advanced Pharmacy Education & Research 2, 113-119 (2011).
9. Rupal, J., Kaushal, J., Mallikarjuna, S.C. &Dipti, P. Preparation and Evaluation of Solid Dispersions of Aceclofenac. International Journal of Pharmaceutical Sciences and Drug Research 1, 32-35 (2009).
10. Aleem, M., Dehghan, M. & Rajesh Babu, V. Solid Dispersion-An approach to enhance the dissolution rate of Aceclofenac by using 3 2 Factorial Design. International Journal of Pharmaceutical Sciences and Research 1, 203-208 (2010).
11. Dua, K., Pabreja, K. &Ramana, M. Preparation, Characterization and In Vitro Evaluation of Aceclofenac Solid Dispersions. ARS Pharmaceutica 51, 57-76 (2010).
12. Patil, S.R., RaniKumar, M., Patil, M.S.P. &Rao, V.S.N.M. Enhancement of Dissolution Rate of Aceclofenac by Solid Dispersion Technique. International Journal of PharmTech Research 1, 1198-1204 (2009).
13. Sunitha, N. Formulation and Evaluation of Aceclofenac Solid Dispersions for Dissolution Rate Enhancement. International Journal of Pharmaceutical Sciences and Drug Research 2, 146-150 (2010).
14. Gulzar, A., Kumar, K., Gbgb, Bp, S.K. &Ar, H. Formulation and evaluation of solid dispersion of Aceclofenac. International Journal of Advances in Pharmaceutical Sciences 1, 77-82 (2010).
15. Bhupendra Kumar Tiwari, V.G.A.J. &Pandey, A. Enhancement of solubility of aceclofenac by using different solubilization technique. International Journal of Pharmacy & Life Sciences 2, 620-624 (2011).
16. Rajesh, M. &Arpna, I. Novel application of mixed hydrotropic solubilization technique in the formulation and evaluation of hydrotropic solid dispersion of aceclofenac. Asian Journal of Pharmaceutics 4, 235-238 (2010).
17. Kulkarni, U. Design and development of aceclofenac fast dissolving tablets by amorphous solid dispersion technique using modified aeglemarmelos gum. International Journal of Pharmaceutical Research &Development 3, 201-210 (2011).
18. Maulvi, F.A. et al. Improvement of dissolution rate of aceclofenac by solid dispersion technique. Powder Technology 207, 47-54 (2011).
19. Patel, A.R. & Joshi, V.Y. Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion. AAPS PharmSciTech 9, 583-590 (2008).
20. Tran, P.H.L., Tran, H.T.T. & Lee, B.J. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. Journal of Controlled Release 129, 59-65 (2008).
21. Tran, T.T.D., Tran, P.H.L., Choi, H.G., Han, H.K. & Lee, B.J. The roles of acidifiers in solid dispersions and physical mixtures. International Journal of Pharmaceutics 384, 60-66 (2010).
22. Ha, N.S., Tran, T.T.D., Tran, P.H.L., Park, J.B. & Lee, B.J. Dissolution-Enhancing Mechanism of Alkalizers in Poloxamer-Based Solid Dispersions and Physical Mixtures Containing Poorly Water-Soluble Valsartan. Chemical and Pharmaceutical Bulletin 59, 844-850 (2011).
23. Tran, P.H.L. et al. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage. International Journal of Pharmaceutics 414, 48--55 (2011).
24. Riis, T., Bauer-Brandl, A., Wagner, T. &Kranz, H. pHindependent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations. European Journal of Pharmaceutics and Biopharmaceutics 65, 78-84 (2007).
25. Kranz, H., Guthmann, C., Wagner, T., Lipp, R. &Reinhard, J. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. European Journal of Pharmaceutical Sciences 26, 47-53 (2005).
26. Siepe, S., Lueckel, B., Kramer, A., Ries, A. &Gurny, R. Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH. International Journal of Pharmaceutics 316, 14-20 (2006).
27. Damian, F., Blaton, N., Kinget, R. & Van den Mooter, G. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. International Journal of Pharmaceutics 244, 87-98 (2002).
28. Damian, F. et al. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. European Journal of Pharmaceutical Sciences 10, 311-322 (2000).
29. Barker, S. et al. An investigation into the structure and bioavailability of [alpha]-tocopherol dispersions in Gelucire 44/14. Journal of controlled release 91, 477-488 (2003).
30. Karatacs, A., Yuksel, N. &Baykara, T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. IlFarmaco 60, 777-782 (2005).
31. Mutalik, S., Anju, P., Manoj, K. &Usha, A.N. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosanbased solvent change approach. International Journal of Pharmaceutics 350, 279-290 (2008).
32. Wurster, D.E. & Taylor Jr, P.W. Dissolution kinetics of certain crystalline forms of prednisolone. Journal of Pharmaceutical Sciences 54, 670-676 (1965).
33. Sciarra, J. & Patel, S. In vitro release of therapeutically active ingredients from polymer matrixes. Journal of Pharmaceutical Sciences 65, 1519-1522 (1976).
34. Brockmeier, D. In vitro/in vivo correlation of dissolution using moments of dissolution and transit times. Actapharmaceuticatechnologica 32, 164-174 (1986).
35. Voegele, D., Brockmeier, D. & von Hattingberg, H. Modelling of input function to drug absorption by moments. Proceedings of the symposium on compartmental and noncompartmentalmodelling in pharmacokinetics, Smolenice, Czechoslovakia, September 12-16 (1988).
36. Pinto, J.F., Podczeck, F. & Newton, J.M. The use of statistical moment analysis to elucidate the mechanism of release of a model drug from pellets produced by extrusion and spheronisation. Chemical and Pharmaceutical Bulletin 45, 171-180 (1997).
37. Estella-Hermoso de Mendoza, A., Rayo, M., Mollinedo, F. & Blanco-Prieto, M.J. Lipid nanoparticles for alkyl lysophospholipidedelfosine encapsulation: Development and in vitro characterization. European Journal of Pharmaceutics and Biopharmaceutics 68, 207-213 (2008).
38. Costa, P. & Sousa Lobo, J.M. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 13, 123-133 (2001).
39. Dahiya, S., Kaushik, A. & others Effect of water soluble carriers on dissolution enhancement of aceclofenac. Asian Journal of Pharmaceutics 4, 34-39 (2010).
40. Costa, F., Sousa, J., Pais, A. &Formosinho, S. Comparison of dissolution profiles of ibuprofen pellets. Journal of controlled release 89, 199-212 (2003).
41. Park, S.H. & Choi, H.K. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. International Journal of Pharmaceutics 321, 35-41 (2006).
42. Balakrishnan, A., Rege, B.D., Amidon, G.L. &Polli, J.E. Surfactantmediated dissolution: Contributions of solubility enhancement and relatively low micelle diffusivity. Journal of pharmaceutical sciences 93, 2064-2075 (2004).
43. Parejiya, P.B., Barot, B.S., Patel, H.K. &Shelat, P.K. Development and Characterization of Once a Daily Tablet Formulation of Aceclofenac. International Journal of Pharmaceutical Research 2, 56-61 (2010).
44. Rahman, Z., Zidan, A.S. & Khan, M.A. Formulation and evaluation of a protein-loaded solid dispersions by nondestructive methods. The AAPS journal 12, 158-170 (2010).
45. Perissutti, B., Newton, J.M., Podczeck, F. &Rubessa, F. Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form. European Journal of Pharmaceutics and Biopharmaceutics 53, 125-132 (2002).
46. Nagabhushanam, M. &Sudha, R. Dissolution enhancement of mefenamic acid using solid dispersions in crospovidone. International Journal of Pharmacy and Pharmaceutical Sciences 3, 16-19 (2011).
47. Akiladevi, D., Shanmugapandiyan, P., Jebasingh, D. &Basak, S. Preparation and evaluation of paracetamol by solid dispersion technique. International Journal of Pharmacy and Pharmaceutical Sciences 3, 188-191 (2010).
48. Lalitha, Y. & Lakshmi, P. Enhancement of dissolution of Nifedipine by surface solid dispersion technique. International Journal of Pharmacy and Pharmaceutical Sciences 3, 41-46 (2011).
49. Vanitasagar, S., Srinivas, C., Subhashini, N. &Mallesh, K. Solid dispersion-a comparative study on the dissolution rate of Aceclofenac. International Journal of Pharmacy and Pharmaceutical Sciences 4, 274-278 (2012).
50. Khaleel, N.Y., Abdulrasool, A.A., Ghareeb, M.M. &Hussain, S.A. Solubility and dissolution improvement of Ketoprofen by solid dispersion in polymer and surfactant using solvent evaporation method. International Journal of Pharmacy and Pharmaceutical Sciences 3, 431-435 (2011).
51. Okimoto, K. et al. Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. International Journal of Pharmaceutics 159, 85-93 (1997).
52. Suzuki, H., Miyamoto, N., Masada, T., Hayakawa, E. & Ito, K. Solid dispersions of benidipine hydrochloride. I. Preparations using different solvent systems and dissolution properties. Chemical and Pharmaceutical Bulletin 44, 364-371 (1996).
53. Barzegar-Jalali, M. et al. Enhancing dissolution rate of carbamazepine via cogrinding with crospovidone and hydroxypropylmethylcellulose. Iranian Journal of Pharmaceutical Research 6, 159-165 (2010).
54. Chen, Y. et al. Preparation and characterization of emulsified solid dispersions containing docetaxel. Archives of Pharmacal Research 34, 1909-1917 (2011).
55. Zhen-ping, W., Shi-rui, M., Dian-zhou, B. & Yong, L. Dissolution improvement of cisapride by solid dispersion with HPMC. Journal of Chinese Pharmaceutical Sciences 13, 245-258 (2004).
56. Sharma, A. & Jain, C. Solid dispersion: A promising technique to enhance solubility of poorly water soluble drug. International Journal of Drug Delivery 3, 149-170 (2011).
57. Ahuja, N., Katare, O.P. & Singh, B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. European Journal of Pharmaceutics and Biopharmaceutics 65, 26-38 (2007).
58. Saygili, M., Uzunkaya, G., OZSOY, Y. &Araman, A. Enhanced dissolution rate of tiaprofenic acid using Gelucire 44/14. ScientiaPharmaceutica 70, 295-307 (2002).
59. Srinarong, P. et al. Surface-active derivative of inulin (Inutec SP1) is a superior carrier for solid dispersions with a high drug load. Journal of pharmaceutical sciences 100, 2333-2342 (2011).
60. Nedyalkov, M., Alexandrova, L., Platikanov, D., Levecke, B. &Tadros, T.F. Wetting properties of aqueous solutions of hydrophobically modified inulin polymeric surfactant. Colloid & Polymer Science 286, 713-719 (2008).
61. Van den Mooter, G., Weuts, I., De Ridder, T. &Blaton, N. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. International Journal of Pharmaceutics 316, 1-6 (2006).
62. Basalious, E.B., El-Sebaie, W. & El-Gazayerly, O. Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants and Crystallization Inhibitors: Development of Controlled-Release Tablets. AAPS PharmSciTech 12, 799-810 (2011).
63. Makky, A.M., Ahmed, I.S., El-Nabarawi, M.A. & El-Moneim, R.A.A. Development of a New Carvedilol Tablet with Rapid Onset of Action. American Journal of Drug Discovery and Development 2, 55-71 (2012).
64. Ibrahim, M.M., El-Nabarawi, M., El-Setouhy, D.A. &Fadlalla, M.A. Polymeric Surfactant Based Etodolac Chewable Tablets: Formulation and In Vivo Evaluation. AAPS PharmSciTech 11, 1730-1737 (2010).
65. Gotchev, G., Exerowa, D., Khristov, K., Levecke, B. &Tadros, T. Stability of O/W Emulsion Films from Mixed Aqueous Solutions of Inulin-Based Polymeric and Polyethylene Glycol Surfactants. Journal of Dispersion Science and Technology 31, 31-37 (2009).
66. Liu, C., Desai, K.G.H., Liu, C. & Park, H.J. Enhancement of dissolution rate of rofecoxib using solid dispersions with urea. Drug Development Research 63, 181-189 (2004).
67. Ali, A. &Gorashi, A. Absorption and dissolution of nitrofurantoin from different experimental formulations. International Journal of Pharmaceutics 19, 297-306 (1984).
68. Jachowicz, R. Dissolution rates of partially water-soluble drugs from solid dispersion systems. I. Prednisolone. International Journal of Pharmaceutics 35, 1-5 (1987).
69. Okonogi, S., Oguchi, T., Yonemochi, E., Puttipipatkhachorn, S. & Yamamoto, K. Improved dissolution of ofloxacin via solid dispersion. International Journal of Pharmaceutics 156, 175-180 (1997).
70. Ghebremeskel, A.N., Vemavarapu, C. &Lodaya, M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Selection of polymer-surfactant combinations using solubility parameters and testing the processability. International Journal of Pharmaceutics 328, 119-129 (2007).
71. Bowen, W. et al. Biopharmaceutics Applications in Drug Development. A Biopharmaceutical Classification System Approach to Dissolution: Mechanisms and Strategies. 290-316 (Springer: 2008).
72. Owusu-Ababio, G., Ebube, N.K., Reams, R. &Habib, M. Comparative dissolution studies for mefenamic acidpolyethylene glycol solid dispersion systems and tablets. Pharmaceutical development and technology 3, 405-412 (1998).
73. Shokri, J., AZARMI, S., SABOURI, A. &Shokri, M. Enhancement of oxazepam dissolution rate using oxazepam-surfactant solid dispersions. Pharmaceutical Sciences 4, 4 (2006).
74. Sheen, P.C., Khetarpal, V.K., Cariola, C.M. &Rowlings, C.E. Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. International Journal of Pharmaceutics 118, 221-227 (1995).
75. Hu, J., Johnston, K.P., Williams, R.O. & others Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems. European Journal of Pharmaceutical Sciences 20, 295-303 (2003).
76. Leuner, C. &Dressman, J. Improving drug solubility for oral delivery using solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics 50, 47-60 (2000).
77. Samy, A., Marzouk, M., Ammar, A. & Ahmed, M. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique. Drug discoveries & therapeutics 4, 77 (2010).
78. Shah, J., Vasanti, S., Anroop, B. &Vyas, H. Enhancement of dissolution rate of valdecoxib by solid dispersions technique with PVP K 30 \& PEG 4000: preparation and in vitro evaluation. Journal of Inclusion Phenomena and Macrocyclic Chemistry 63, 69-75 (2009).
79. Patel, R. & Patel, M. Preparation, characterization, and dissolution behavior of a solid dispersion of simvastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Journal of Dispersion Science and Technology 29, 193-204 (2008).
80. Laitinen, R. et al. Intraorally fast-dissolving particles of a poorly soluble drug: Preparation and in vitro characterization. European Journal of Pharmaceutics and Biopharmaceutics 71, 271-281 (2009).
81. Threlfall, T.L. Analysis of organic polymorphs. A review. Analyst 120, 2435-2460 (1995).
82. Tantishaiyakul, V., Kaewnopparat, N. &Ingkatawornwong, S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. International Journal of Pharmaceutics 143, 59-66 (1996).
83. Tantishaiyakul, V., Kaewnopparat, N. &Ingkatawornwong, S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. International Journal of Pharmaceutics 181, 143-151 (1999).
84. Govindarajan, M., Periandy, S. &Ganesan, K. Scaled Quantum FT-IR and FT-Raman Spectral Analysis of 1-Methoxynaphthalene. Journal of Chemistry 7, 457-464 (2010).
85. Sahoo, S., Chakraborti, C. & Mishra, S. FTIR and Raman Spectroscopic Investigations of Controlled Release Ofloxacin/HPMC Mucoadhesive Suspension. International Journal of Pharmacy & Technology 3, (2011).